4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-026444
Options or other derivatives
- Chief Commercial Officer acquired 132,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kirby Daniel Gordon Chief Commercial Officer | 2026-03-09 | Grant or award · Restricted Stock Units | +132,200 | 132,200 | D: show line 1 in the form |
Loading xslF345X05/tm268453-2_4seq1.xml…